Reduction-oxidation (Redox) and vascular tissue level of homocyst(e)ine in human coronary atherosclerotic lesions and role in extracellular matrix remodeling and vascular tone

Molecular and Cellular Biochemistry

Volumn 181, Issue 1-2, 1998, Pages 107-116

  Tyagi, Suresh C ^a   Smiley, Lane M ^a   Mujumdar, Vibhas S ^b   Clonts, Brian ^b   Parker, Janet L ^b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b University of Missouri   (United States)

Author keywords

Atherosclerosis; Collagen; Collagenase; Extracellular matrix; Homocyst(e)ine; Matrix metalloproteinase; Occlusive coronary heart disease; Oxidative mixed disulfide; Remodeling; Vascular tone; Vasoconstriction

Indexed keywords

COLLAGENASE; DISULFIDE; HOMOCYSTINE; TISSUE EXTRACT; TRICHLOROACETIC ACID;

ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL TONE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY;

ARTERIES; CELL EXTRACTS; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; CULTURE TECHNIQUES; CYSTEINE; CYSTINE; DISULFIDES; DITHIONITROBENZOIC ACID; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; HOMOCYSTEINE; HOMOCYSTINE; HUMANS; ISOMETRIC CONTRACTION; METALLOENDOPEPTIDASES; OXIDATION-REDUCTION; VASOCONSTRICTION;

EID: 0031931045     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006882014593     Document Type: Article

References (35)

1. Boers GHJ, Smals AGH, Trijbels FJM, Bakkeren JAJM, Schoonderwalt HC, Kloppenborg PWC: Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease, N Eng J Med 313: 709-715, 1985
2. Brattstrom LE, Hardebo JE, Hultberg BL: Moderate homocysteinemia - a possible risk factor for arteriosclerotoc cerebrovascular disease, Stroke 15: 1012-1016, 1984
3. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I: Hyperhomocysteinemia: An independent risk factor for vascular disease. N Eng J Med 324: 1149-1155, 1991
4. Coull BM, Malinow MR, Beamer N, Sexton G, Nordt F, DeGarmo P: Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Stroke 21: 572-576, 1990
5. Harker LA, Harlan JM, Ross R: Effect of sulfinpyrazone on homocysteine induced endothelial injury and arterioclerosis in baboons. Circ Res 53: 731-739, 1983
6. Tsai J-C, Perrella MA, Yoshizumi M, Hsieh C-M, Haber E, Schegel R, Lee M-E: Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis. Proc Natl Acad Sci (USA) 91: 6369-6373, 1994
7. Alfthan G, Pekkanen J, Jauhainen M, Pitkaniemi J, Karvonen M, Tuomileto J, Salonen JT, Enholm C: Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 106: 9-18, 1994
8. Ross R: The pathogenesis of atherosclerosis. Nature 362: 801, 1993
9. Barnes MJ: Collagens in atherosclerosis. Coll Relat Res 5: 65, 1985
10. Tyagi SC, Meyer L, Schmaltz RA, Reddy HK, Voelker DJ: Proteinases and restenosis: Matrix metalloproteinase and their inhibitor and activator. In: LL Gallo (ed). Cardiovascular Disease II: Cellular and Molecular Mechanisms, Prevention. Plenum Publishing Corp., NY, 1995, pp 19-31
11. Tyagi SC, Meyer L, Schmaltz RA, Reddy HK, Voelker DJ: Proteinases and restenosis in human coronary artery: Extracellular matrix production exceeds the expression of proteolytic activity. Atherosclerosis 116: 43-57, 1995
12. Tyagi SC, Meyer L, Kumar SG, Schmaltz RA, Reddy HK, Voelker DJ: Induction of tissue inhibitor of metalloproteinase and its mitogenic response to endothelial cells in human atherosclerotic and restenotic lesions. Canad J Cardiol 12: 353-362, 1996
13. Tyagi SC, Haas SJ, Kumar SG, Reddy HK, Voelker DJ, Hayden MR, Demmy XL, Schmaltz RA, Curtis JJ: Post-trancriptional regulation of extracellular matrix metalloproteinse in human heart end-stage failure secondary to ischemic cardiomyopathy. J Mol Cell Cardiol 28: 1415-1428, 1996
14. Tyagi SC, Kumar SG, Alla SR, Reddy HK, Voelker DJ, Janicki JS: Extracellular matrix regulation of metalloproteinase and antiproteinase in human heart fibroblast cells. J Cell Physiol 167: 137-147, 1996
15. Tyagi SC, Campbell SE, Reddy HK, Tjahja E, Voelker DJ: Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts. Mol Cell Biochem 15 5: 13-21, 1996
16. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976
17. Wilson JM,Wu D, Motiu-Degrood R, Hupe DJ : A spectroscopic method for studying the role of reaction of disulfide with protein thiol groups applied to bovine serum albumin. J Am Chem Soc 102: 7863-7867, 1980
18. Tyagi SC: Role of oxidative mixed disulfide formation in elastase-serine proteinases inhibitor (serpin) complex. Biochem Cell Biol 74: 391-401, 1996
19. Tyagi SC, Matsubara L, Weber KT: Direct extraction and estimation of collagenase(s) activity by zymography in microquantities of rat myocardium and uterus. Clin Biochem 26: 191-198, 1993
20. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature 227: 680-685, 1970
21. Mebazaa A, Wetzel R, Cherian M, Abraham M: Comparison between endocardial and great vessel endothelial cells, morphology, growth, and prostaglandin release. Am J Physiol 268: H250-H259, 1995
22. De Keulenaer GW, Andries LJ, Sys SU, Brutsaert DL: Endothelin-mediated positive inotropic effect induced by reactive oxygen species in isolated cardiac muscle. Circ Res 76: 878-884, 1995
23. Tyagi SC, Simon SR: Role of disulfide exchange in alpha 1-proteinase inhibitor. Biochemistry 31: 10584-10590, 1992
24. Welch GN, Farivar RS, Upchurch GR, Brecher PI, Loscalzo J: Homocysteine facilitates activation of NOS2 in vascular smooth muscle cells through NF KappaB - dependent mechanism. Circulation 94: I-220, 1996
25. Malinow MR, Kang SS, Taylor LM, Wong PWK, Coull B, Inahara T, Mukerkee D, Sexton G, Upson B: Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation 79: 1180-1188, 1989
26. 6, pyridoxal phosphate, and folate. Am J Cardiol 75: 1107-1111, 1995
27. Springman EB, Angleton EL, Birkedal-Hansen H, Van Wart HE: Multiple modes of activation of latent human fibroblast collagenase evidence for the role of a Cys 73 active-site sine complex in latency and a 'cysteine switch' mechanism for activation. Proc Natl Acad Sci USA 87: 364-368, 1990
28. Tyagi SC, Ratajaska A, Weber KT: Myocardial matrix metallo-proteinases: Activation and localization. Mol Cell Biochem 126: 49-59, 1993
29. Cook ME, Bai Y, Orth MW: Factors influencing growth plate cartilage turnover. Poultry Science 73: 889-996, 1994
30. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K: Growth promoting activity of TIMP-1 for a wide range of cells. FEBS Lett 298: 29-32, 1992
31. Asano H, Shimizu K, Muramatsu M, Iwama Y, Miyazaki Y, Okumura K, Hashimoto H, Ito T: Prostaglandin H2 as an endothelium-derived contracting factor modulates endothelin-linduced contraction. J Hypert 12: 383-390, 1994
32. Zochodne DW, Ho LT, Gross PM: Acute endoneurial ischemia induced by epineurial endothelin in the rat sciatic nerve. Am J Physiol 263: H1806-H1810, 1992
33. Kiowski W, Sutch G, Hunziker P, Kim J, Oechslin E, Schmott R, Jones R, Bertel O: Evidence for endothelin-1 mediated vaso- constriction in severe chronic heart failure. Lancet 346: 732-736, 1995
34. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, Loscalzo J: Adverse vascular effects of homocystine are modulated by endothelial-derived relaxing factor and related oxides of nitrogen. J Clin Invest 91: 308-318, 1993
35. Mansoor MA, Svardal AM, Ueland PM: Determination of the in vivo redox status of cysteine, cysteineglycine, homocysteine and glutathione in human plasma. Anal Biochem 200: 218-229, 1992